Cancer Research

Pancreatic cancer, recognized for its aggressive nature and limited treatment options, remains one of the most challenging malignancies to manage. Researchers at the Perelman School of Medicine, University of Pennsylvania, and Penn Medicine's Abramson Cancer Center have recently unveiled

Applying sound waves for a smarter solution - the potential role of ultrasound in cancer treatment is a burgeoning field. Carolyn Schutt Ibsen, a prominent figure in biomedical engineering, is at the forefront of this innovation. Her remarkable transition from childhood curiosity to groundbreaking

The oversight practices of the Food and Drug Administration (FDA) regarding food additives and substances have come under scrutiny. This article explores the FDA's regulation of food safety, the autonomy granted to food companies, and the health risks associated with certain ingredients,

The University of Colorado Comprehensive Cancer Center (CU Cancer Center) and Flatiron Health have joined forces to revolutionize the efficiency of clinical trials by significantly reducing the administrative workload traditionally placed on researchers. By integrating Flatiron Clinical Pipe with

The pharmaceutical industry is abuzz with excitement over a new class of cancer drugs known as PD-1/VEGF inhibitors. These promising therapies, currently undergoing clinical trials, might leapfrog Merck & Co.’s highly successful cancer immunotherapy, Keytruda. The advent of these new drugs c

Parkinson's disease, a devastating neurodegenerative disorder, is characterized by the relentless loss of dopaminergic neurons, which leads to significant motor dysfunction and a decline in overall quality of life. Central to the pathology of PD are aggregates of alpha-synuclein protein and